George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,926.00
Bid: 2,022.00
Ask: 1,830.00
Change: 45.50 (2.42%)
Spread: -192.00 (-9.496%)
Open: 1,903.00
High: 1,937.50
Low: 1,887.50
Prev. Close: 1,880.50
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

16 Mar 2016 07:13

Currency headwinds push Hikma Pharmaceuticals profits down

(ShareCast News) - Drug group Hikma Pharmaceuticals reported revenue of $1.44bn (£1.02bn) in its final results for 2015 on Wednesday, down 3% on what was an exceptionally strong 2014. Its gross margin remained in line with 2014, at 56.8%, reflecting Hikma's cost control efforts across the business.

Read more
9 Mar 2016 16:12

Earnings, Trading Statements Calendar - Week Ahead

Read more
2 Mar 2016 17:37

Sports Direct to drop out of FTSE 100 in reshuffle

* WM Morrison, Paddy Power and Betfair to join FTSE 100 * Informa and Mediclinic to also join FTSE 100 * Sports Direct, Aberdeen AM, Smiths, Hikma drop out * Changes will take effect on March 21 By Sudip Kar-Gupta LONDON, March 2 (Reuters) - Sports Direct and Aberdee

Read more
2 Mar 2016 17:25

Paddy Power Betfair, Mediclinic, Informa And Morrisons Join FTSE 100

Read more
1 Mar 2016 15:19

Morrisons set for FTSE 100 return, Sports Direct in line for demotion

(ShareCast News) - Morrisons, which announced a new grocery supply deal with Amazon.com on Monday, may work its way back into the FTSE 100 this month. The supermarket retailer, which was booted out at the last quarterly review, could be joined by newly-merged Paddy Power Betfair and private hospital

Read more
26 Feb 2016 17:29

U.S. sets conditions for Hikma's takeover of Boehringer's Roxane

WASHINGTON, Feb 26 (Reuters) - Drug manufacturer Hikma Pharmaceuticals Plc will sell the rights and assets of two generic drugs and relinquish its U.S. marketing rights to a third generic drug in order to settle Federal Trade Commission charges that Hikma's proposed $2 billion acquisition of Roxa

Read more
22 Feb 2016 12:00

Hikma hires well-connected American

(ShareCast News) - Hikma Pharmaceuticals has appointed US public affairs veteran John Castellani to its board. The FTSE 100 pharmaceuticals company said the appointment, which is effective from March 1, will see him join the the audit, remuneration, and compliance, responsibility and ethics committe

Read more
22 Feb 2016 10:23

WINNERS & LOSERS SUMMARY: HSBC Warns Of "Bumpier" Road For Finance

Read more
22 Feb 2016 09:58

Hikma Pharmaceuticals Appoints Ex-US Industry Body Chief To Board

Read more
19 Feb 2016 09:36

BROKER RATINGS SUMMARY: Macquarie Starts Burberry At Outperform

Read more
19 Feb 2016 08:21

LONDON BRIEFING: Coca-Cola HBC And Standard Life Impress With Results

Read more
18 Feb 2016 09:31

BROKER RATINGS SUMMARY: JPMorgan Raises Auto Trader To Overweight

Read more
12 Feb 2016 15:59

AGM, EGM Calendar - Week Ahead

Read more
11 Feb 2016 09:37

BROKER RATINGS SUMMARY: Panmure Gordon Raises DCC To Buy After Update

Read more
10 Feb 2016 14:26

FTSE 100 movers: Housebuilders lead market higher

(ShareCast News) - The FTSE 100 was set to turn things around on Wednesday, with the blue chip market up 48.39 points (0.86%) to 5,680.58 by mid-afternoon. Housebuilders were on the rise, including Taylor Wimpey, Berkeley Group Holdings and Barratt Developments, after sector peer Bellway reported st

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.